USD 0.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2009 | 38.88 Thousand USD | 0.0% |
2006 | 52.05 Thousand USD | -5.64% |
2005 | 55.17 Thousand USD | -97.83% |
2004 | 2.53 Million USD | 371.25% |
2003 | 538.63 Thousand USD | 3068.44% |
2002 | 17 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2009 FY | 38.88 Thousand USD | 0.0% |
2007 Q2 | 6788.00 USD | 101.48% |
2007 Q1 | 3369.00 USD | 109.8% |
2007 Q3 | 6788.00 USD | 0.0% |
2006 Q1 | 255.12 Thousand USD | 149.43% |
2006 FY | 52.05 Thousand USD | -5.64% |
2006 Q4 | -34.36 Thousand USD | -441.03% |
2006 Q3 | 10.07 Thousand USD | -27.72% |
2006 Q2 | 13.94 Thousand USD | -94.54% |
2005 Q1 | 435.14 Thousand USD | -63.96% |
2005 FY | 55.17 Thousand USD | -97.83% |
2005 Q4 | -516.17 Thousand USD | -478.97% |
2005 Q3 | 136.2 Thousand USD | 500.06% |
2005 Q2 | 22.69 Thousand USD | -94.78% |
2004 Q4 | 1.2 Million USD | 250.32% |
2004 Q2 | 343.48 Thousand USD | -56.19% |
2004 Q1 | 784.09 Thousand USD | 89.66% |
2004 FY | 2.53 Million USD | 371.25% |
2004 Q3 | 344.67 Thousand USD | 0.35% |
2003 Q2 | - USD | -100.0% |
2003 FY | 538.63 Thousand USD | 3068.44% |
2003 Q1 | 3582.00 USD | 463.65% |
2003 Q4 | 413.43 Thousand USD | 239.93% |
2003 Q3 | 121.62 Thousand USD | 0.0% |
2002 FY | 17 Thousand USD | 0.0% |
2002 Q4 | -985.00 USD | -152.56% |
2002 Q3 | 1874.00 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Bio Medica Corporation | 1.04 Million USD | 96.294% |
Arrayit Corporation | 6.19 Million USD | 99.373% |
Atlantic International Corp. | 5.57 Million USD | 99.303% |
Biocept, Inc. | 29.4 Million USD | 99.868% |
Bioqual, Inc. | 7.44 Million USD | 99.478% |
CardioGenics Holdings Inc | 772.14 Thousand USD | 94.965% |
DermTech, Inc. | 104.01 Million USD | 99.963% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 99.977% |
HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 99.828% |
iMD Companies, Inc. | 151.8 Thousand USD | 74.388% |
IDenta Corp. | 662.97 Thousand USD | 94.135% |
Interpace Biosciences, Inc. | 20.23 Million USD | 99.808% |
InVitro International | 661.32 Thousand USD | 94.121% |
Lumos Diagnostics Holdings Limited | 7.09 Million USD | 99.452% |
Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | 33.093% |
Medical Imaging Corp. | 1.91 Million USD | 97.967% |
NovelStem International Corp. | 3.53 Million USD | 98.901% |
Optigenex Inc. | 1.28 Million USD | 96.981% |
PharmChem, Inc. | 2.93 Million USD | 98.674% |
Proteome Sciences plc | 3.26 Million USD | 98.81% |
Response Genetics, Inc | 25.31 Million USD | 99.846% |
Rennova Health, Inc. | 7.67 Million USD | 99.494% |
RushNet, Inc. | 1.78 Million USD | 97.827% |
ScreenPro Security Inc. | 3.23 Million USD | 98.8% |
Stella Diagnostics Inc. | 11.42 Million USD | 99.66% |
StageZero Life Sciences Ltd. | 7.34 Million USD | 99.471% |
Todos Medical Ltd. | 14.05 Million USD | 99.723% |